Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Free Cash Flow Generation Index
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Free Cash Flow Generation Index of 0.49x as of September 2025. Free cash flow of CN¥1.76 Million represents 0% of operating cash flow (CN¥3.56 Million). Read debt load of Jiangsu Aidea Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jiangsu Aidea Pharmaceutical Co Ltd Free Cash Flow Generation Index (2016–2020)
Historical FCF Generation Index trend for Jiangsu Aidea Pharmaceutical Co Ltd across 3 annual periods. Explore 688488 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2020)
Year-by-year Free Cash Flow Generation Index for Jiangsu Aidea Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Jiangsu Aidea Pharmaceutical Co Ltd (688488) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.24x | CN¥13.74 Million | CN¥56.17 Million | CN¥42.43 Million | ▼ -39.4% |
| 2019 | 0.40x | CN¥22.70 Million | CN¥56.20 Million | CN¥33.50 Million | ▲ +131.8% |
| 2016 | -1.27x | CN¥-39.72 Million | CN¥31.29 Million | CN¥71.01 Million | — |